Corrigendum to ‘Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force’ [IJID 128 (2023) 121–127]
Mayuko Watase, Katsunori Masaki, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, Takahiro Fukushima, Shiro Otake, Kensuke Nakagawara, Tatsuya Kusumoto, Takanori Asakura, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Yoshitaka Oyamada, Norihiro Harada, Tetsuya Ueda
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Obstructive Pulmonary Disease (COPD) Research
The authors would like to point out that the caption for Figure 2 in the published version of their paper contained an error. The correct caption is below:
Figure 2 legend (corrected version):
(a) Incidence of IMV among non-COPD patients classified by PY and COPD patients.
(b) Results of the univariate analysis of need for IMV on all smoker patients (b-1), smoker patients aged 65 years or younger (b-2), and smoker patients over 65 years old (b-3).
**p< 0.001, *p<0.05. IMV, invasive mechanical ventilation; COPD, chronic obstructive pulmonary disease; PY, pack-year.